Vancouver’s Vistara Growth is going down under with their newest investment.
Vistara is leading a USD $25 million growth investment into Brisbane, Australia’s VALD, an international phenom that has applied human measurement technologies to revolutionize musculoskeletal healthcare in professional sport, defence, clinical and hospital settings.
VALD’s range of human measurement technologies democratizes access to musculoskeletal technology to improve data-driven decision making. The company’s platform has been used by professional sports teams across the globe to better monitor athlete performance, injury and recovery.
Over the past several years, the company has brought their platform and expertise to healthcare practitioners, helping them improve outcomes for patients.
VALD Co-founder and CEO, Mr. Laurie Malone, is confident the investment from Vistara will provide strategic benefit in the North American market, where VALD products have seen the most adoption and generate over 50% of the company’s revenues.
“This partnership with Vistara Growth will accelerate our ongoing North American expansion and allow us to make further inroads into the healthcare market worldwide,” Malone said. “We like to say that after helping teams win sporting championships, we’re now helping grandmothers successfully recover from hip surgery so they can pick up their grandkids again.”
Joining Vistara in the round was the Queensland Business Innovation Fund, managed by Queensland Investment Corp, a leading Australian-based pension fund and existing investor in the company.
Noah Shipman, Partner at Vistara Growth, is excited by the partnership with VALD, Vistara’s first Australian investment.
“VALD is the type of highly ambitious, disciplined and globally minded technology company Vistara Growth seeks to invest in. We are excited to back our first Australian-based company and see VALD as the world leader in their market,” says Shipman.
“VALD’s human measurement technology had been battle tested by the world’s most demanding customers in professional sport and defence organisations,” Shipman continues, “With rapid early adoption in healthcare settings, it was time to prepare for global expansion, and we are thrilled to be VALD’s partner in driving this next phase of growth”.
Leave a Reply